跳至主要内容
临床试验/NCT07263165
NCT07263165尚未招募不适用

Effect of Adding Dexmedetomidine as Adjuvant to Bupivacaine in Ultrasound Guided External Oblique Intercostal Plane Block in Upper Abdominal Cancer Surgery. A Prospective Randomized Clinical Trial

Assiut University0 个研究点目标入组 54 人开始时间: 2025年12月15日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
54
主要终点
Total Postoperative Opioid Consumption (mg of morphine equivalents)

研究概览

简要总结

Effect of Adding Dexmedetomidine as Adjuvant toBupivacaine in Ultrasound Guided ExternalOblique Intercostal Plane Block in UpperAbdominal Cancer Surgery.

详细描述

Effect of Adding Dexmedetomidine as Adjuvant toBupivacaine in Ultrasound Guided ExternalOblique Intercostal Plane Block in UpperAbdominal Cancer Surgery. A prospectiverandomized clinical trial

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18-70 years scheduled for elective upper abdominal cancer surgery (e.g., gastrectomy, hepatectomy, pancreatectomy).
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Body mass index (BMI) between 18-35 kg/m².

排除标准

  • Patient refusal.
  • Allergy to local anesthetics or dexmedetomidine.
  • Coagulopathy (INR >1.5, platelet count <100,000/mm³).
  • Infection at the injection site.
  • Severe cardiopulmonary, renal, or hepatic dysfunction.
  • Chronic opioid use (>30 mg morphine equivalents daily for >3 months).
  • Pregnancy or lactation.

研究组 & 干预措施

Dexmedetomidine + Bupivacaine

Experimental

Participants will receive an ultrasound-guided external oblique intercostal plane block using 20 mL of 0.25% bupivacaine combined with dexmedetomidine (0.5 µg/kg) administered as a single-shot injection.

干预措施: Dexmedetomidine (Drug)

Bupivicaine

Active Comparator

Participants will receive an ultrasound-guided external oblique intercostal plane block using 20 mL of 0.25% bupivacaine administered as a single-shot injection without any adjuvant.

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Total Postoperative Opioid Consumption (mg of morphine equivalents)

时间窗: 24 hours postoperative.

To evaluate the effect of adding dexmedetomidine to bupivacaine on total opioid consumption within the first 24 hours after upper abdominal cancer surgery.

次要结局

  • Postoperative Pain Intensity Using the Visual Analog Scale (VAS 0-10)(2, 4, 6, 12, 18, and 24 hours postoperative.)
  • Time to First Request for Rescue Analgesia.(24 hour postoperative)
  • Number of Participants with Adverse Effects(first 2 hours postoperative.)
  • patient satisfaction score(1 hour postoperative)
  • Block-related complications.(intraoperative and 24 postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Ibrahem Shaker

Anesthesia Resident

Assiut University

相似试验